α-1抗胰蛋白酶在新型冠状病毒肺炎中的治疗应用 - Suppr

Therapeutic Application of Alpha-1 Antitrypsin in COVID-19.

作者信息

Ritzmann Felix, Chitirala Praneeth, Krüger Nadine, Hoffmann Markus, Zuo Wei, Lammert Frank, Smola Sigrun, Tov Naveh, Alagem Noga, Lepper Philipp M, Pöhlmann Stefan, Beisswenger Christoph, Herr Christian, Bals Robert

机构信息

Saarland University Homburg, Germany.

German Primate Center-Leibniz Institute for Primate Research Göttingen, Germany.

出版信息

Am J Respir Crit Care Med. 2021 Jul 15;204(2):224-227. doi: 10.1164/rccm.202104-0833LE.

DOI:10.1164/rccm.202104-0833LE

PMID:33961754

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8650782/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e203/8650782/efceead3fa01/rccm.202104-0833LEf1.jpg

相似文献

Therapeutic Application of Alpha-1 Antitrypsin in COVID-19.

Am J Respir Crit Care Med. 2021 Jul 15;204(2):224-227. doi: 10.1164/rccm.202104-0833LE.

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.

Lancet Respir Med. 2021 Apr;9(4):337-339. doi: 10.1016/S2213-2600(21)00018-7. Epub 2021 Jan 21.

A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.

Trials. 2021 Apr 19;22(1):288. doi: 10.1186/s13063-021-05254-0.

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.

Nat Commun. 2021 Mar 19;12(1):1726. doi: 10.1038/s41467-021-21972-0.

Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?

Eur Respir J. 1997 Oct;10(10):2191-3. doi: 10.1183/09031936.97.10102191.

Medication shortages during the COVID-19 pandemic: Saving more than COVID lives.

Am J Emerg Med. 2021 Jul;45:557-559. doi: 10.1016/j.ajem.2020.07.044. Epub 2020 Jul 24.

Vitamin D and COVID-19: How Much Vitamin D Does a Man Need?

Nutrients. 2021 Nov 29;13(12):4311. doi: 10.3390/nu13124311.

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.

Int J Chron Obstruct Pulmon Dis. 2021 Nov 1;16:2983-2996. doi: 10.2147/COPD.S325211. eCollection 2021.

Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!

COPD. 2010 Jun;7(3):234; author reply 235-6. doi: 10.3109/15412555.2010.485108.

A survey on computational methods in discovering protein inhibitors of SARS-CoV-2.

Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab416.

引用本文的文献

Amino acid residues 655 and 969 in the spike protein of Omicron subvariant BA.1 control use of TMPRSS2 versus Cathepsin L dependent entry pathways and cell tropism.

PLoS One. 2025 Aug 14;20(8):e0328879. doi: 10.1371/journal.pone.0328879. eCollection 2025.

α‑1 Antitrypsin is a potential target of inflammation and immunomodulation (Review).

Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13472. Epub 2025 Feb 28.

Analysis of alpha-1-antitrypsin (AAT)-regulated, glucocorticoid receptor-dependent genes in macrophages reveals a novel host defense function of AAT.

Physiol Rep. 2024 Jul;12(14):e16124. doi: 10.14814/phy2.16124.

Glycoengineered recombinant alpha1-antitrypsin results in comparable and activities to human plasma-derived protein.

bioRxiv. 2024 Mar 30:2024.03.27.587088. doi: 10.1101/2024.03.27.587088.

The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions.

Int J Mol Sci. 2024 Feb 2;25(3):1804. doi: 10.3390/ijms25031804.

Proteomic Evolution from Acute to Post-COVID-19 Conditions.

J Proteome Res. 2024 Jan 5;23(1):52-70. doi: 10.1021/acs.jproteome.3c00324. Epub 2023 Dec 4.

Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog.

BioTech (Basel). 2023 Oct 30;12(4):61. doi: 10.3390/biotech12040061.

Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?

Int J Mol Sci. 2023 Aug 31;24(17):13533. doi: 10.3390/ijms241713533.

Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence.

Biochem Soc Trans. 2023 Jun 28;51(3):1361-1375. doi: 10.1042/BST20230078.

Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution.

Theranostics. 2023 May 8;13(9):2843-2862. doi: 10.7150/thno.83942. eCollection 2023.

本文引用的文献

Therapy for Early COVID-19: A Critical Need.

JAMA. 2020 Dec 1;324(21):2149-2150. doi: 10.1001/jama.2020.22813.

Flagellin shifts 3D bronchospheres towards mucus hyperproduction.

Respir Res. 2020 Aug 26;21(1):222. doi: 10.1186/s12931-020-01486-x.

Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action.

Cell Immunol. 2020 Oct;356:104177. doi: 10.1016/j.cellimm.2020.104177. Epub 2020 Jul 24.

Characterization of the Inflammatory Response to Severe COVID-19 Illness.

Am J Respir Crit Care Med. 2020 Sep 15;202(6):812-821. doi: 10.1164/rccm.202005-1583OC.

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.

Alpha-Antitrypsin Deficiency.

N Engl J Med. 2020 Apr 9;382(15):1443-1455. doi: 10.1056/NEJMra1910234.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD.

Eur Respir J. 2019 Nov 21;54(5). doi: 10.1183/13993003.00673-2019. Print 2019 Nov.

Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection.

Hepatology. 2015 Feb;61(2):437-46. doi: 10.1002/hep.27426.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Therapeutic Application of Alpha-1 Antitrypsin in COVID-19.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献